Delivery Order SPE2DB20D2014-SPE2DB25FB77X

Award Date 4/29/25
Potential Completion Date 5/20/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vyndamax 61 mg capsules, a medication used to treat a specific medical condition. The contract is a firm fixed-price, non-set-aside contract with a ceiling value of $13,846.97 and a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyndamax 61 mg capsules, a medication used to treat a specific medical condition. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and a total ceiling value of $13,846.97. The contract period of performance extends through May 12, 2025. There is no set-aside...
This federal contract award, valued at $13,846.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyndamax 61 mg capsules. The contract is a Firm Fixed Price Delivery Order with a performance period through May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,693.94 fixed-price contract is for the delivery of Vyndamax 61 mg capsules, a medication used to treat a specific condition. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides comprehensive global pharmaceutical support to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyndamax 61 mg capsules. The contract has a firm fixed price of $25,920.62 and is scheduled for completion by September 12, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $25,920.62 contract is for the supply of Vyndamax 61 mg capsules, a medication used in the treatment of heart disease. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,408.24 for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of April 14, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,846.97, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a period of performance through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a period of performance through May 13, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB77X
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vyndamax 61 mg capsules, a medication used to treat a specific condition. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,846.97 and a performance period ending on May 20, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this award, and the company holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 7/29/25, 9:46 AM